Citius Oncology (CTOR) Total Debt (2021 - 2026)

Citius Oncology (CTOR) has reported Total Debt for 6 consecutive years, with $3.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Debt changed 0.0% year-over-year to $3.8 million in Q2 2026; TTM through Jun 2026 was $3.8 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $7.6 million, up 100.0% from the prior year.
• Total Debt was $3.8 million for Q2 2026 at Citius Oncology, roughly flat from $3.8 million in the prior quarter.
• Over five years, Total Debt peaked at $7.6 million in Q3 2025 and troughed at $193164.0 in Q3 2022.
• A 5-year average of $3.2 million and a median of $3.8 million in 2024 frame the typical range for Total Debt.
• Across the five-year window, Total Debt soared 187.89% in 2024 and changed 0.0% in 2025, its largest moves.
• Over 5 years, Total Debt stood at $193164.0 in 2022, then soared by 583.36% to $1.3 million in 2023, then soared by 187.89% to $3.8 million in 2024, then changed by 0.0% to $3.8 million in 2025, then changed by 0.0% to $3.8 million in 2026.
• The last three Total Debt figures came in at $3.8 million (Q2 2026), $3.8 million (Q1 2026), and $3.8 million (Q4 2025), per Business Quant data.